Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
VVCIF: effective April 5,2023: Plan of Arrangement. Shareholders of VIVO will receive 0.2910 of one common share of MediPharm for each VIVO Share held. Fractional shares will be rounded down to the nearest whole number.
FINRA will delete the symbol:
https://otce.finra.org/otce/dailyList?viewType=Deletions
Nothing earth shattering but enough to make good money buying at .06 per share right now. Maybe .30-.50 per share no change in float
… whatcha think buyout range could be via Cronos?
seems to be moving up today. I'm banking on a Cronos buyout
$0.0647 +0.0059 (+10.03%)
Bid x Size $0.0667 x 50,000 Ask x Size $0.0675 x 97,100
What are your thoughts with Vivo? No news on Vertosa drinks or anything on EU GMP certification and both of those happened almost a year ago now. Weren’t they supposed to begin with sales of those drinks last summer also? I mean we are near 52 week low and might be a great opp to hop in but news is completely lacking
again, pps is down but no real volume. I predict share price over .10 by the end of February and that would be a nice 40-50% gain!
No one is selling any large blocks down here. Have to hit the ask to buy more than a few thousand shares
CRON is a likely buyer. May not be an earth shattering deal but VVCIF & CRON have similar revenues and CRON has a nice cash position. The recent VVCIF hires may have something to do with getting a deal done IMO.
I don't know what to think about changes! Does anyone have any opinions or insight?
I don't know what to think about changes! Does anyone have any opinions or insight?
Huge shakeup at Vivo
https://www.newsfilecorp.com/release/89363/VIVO-Announces-Board-Changes
Outstanding Shares
370,896,867
05/31/2021
With you on that. I do not see any MJ opportunities under $0.50
Maybe MEDMEN is a year, but they are raising $10M, CASH again! To open new stores. Something like 650M S/O.
I dumped this pig a long time ago. They became a huge disappointment to me. I loved their unique air-house cultivation facilities but their execution failed.
Too many other cannabis companies will survive. They all cannot. This one won't.
News Release Issued: Apr 15, 2021 (7:00am EDT)
VIVO Cannabis™ Announces Appointment of Ray Laflamme to the Board
TORONTO, April 15, 2021 /CNW/ - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company") is pleased to announce the appointment of Ray Laflamme to the board of directors of the Company (the "Board"), effective as of April 12, 2021.
VIVO Cannabis Inc. (CNW Group/VIVO Cannabis Inc.)
Mr. Laflamme joined VIVO in August 2018, when it acquired Canna Farms Limited, a company co-founded by Mr. Laflamme and the first licensed producer in British Columbia. He currently serves as the President of Canna Farms, which is the Company's largest subsidiary.
"Ray's long history in Canada's legal cannabis market will bring considerable depth of knowledge to the Board with respect to all aspects of the business from seed to sale, as well as invaluable expertise in the areas of quality assurance and regulatory affairs," said Rick Fitzgerald, interim CEO and Chair of the Board. "As our single largest shareholder and a key member of management, he has a clear interest in the successful execution of our business plan and we look forward to his contributions at the Board level."
About VIVO Cannabis™
VIVO Cannabis™ is recognized for trusted, premium cannabis products and services. It holds production and sales licences from Health Canada and operates world-class indoor and seasonal airhouse cultivation facilities. VIVO has a collection of premium brands, each targeting different customer segments, including Canna Farms™, Beacon Medical™, Fireside™, Lumina™ and Canadian Bud Collection™. Harvest Medicine, VIVO's patient-centric, scalable network of medical cannabis clinics, has serviced over 150,000 patient visits. VIVO is pursuing several partnership and product development opportunities and is focusing its international efforts on Germany and Australia. For more information visit: www.vivocannabis.com
ON BEHALF OF THE BOARD OF DIRECTORS
SOURCE VIVO Cannabis Inc.
For further information: VIVO Investor Relations, Michael Bumby, Chief Financial Officer, +1 416-848-9839, ir@vivocannabis.com
You may unsubscribe at any time.
To unsubscribe or change your settings click here:
https://vivocannabis.mediaroom.com/index.php?s=subscribe&code=F8d6wRxTZedlAeuQQK1v7mvEMVXZ4OPZ
How much more can it bleed! When people thought the world was ending w the covid this thing hit .07- there really isn’t more floor to hit IMO. This is MMs and tiny retail trading w themselves. Vivo story will be told (hopefully once they find a fking CEO). But certainly believe if you held this far- shld prob just sit tight. Up from here; new province, Australia coming online, shoppers supply deal, beverage, pharmascience collab, new markets in Germany, Mexico and eventually the US (coming faster than people expect, NY was a sleeping giant IMO)
Ahh thanks! And here I thought things looking better with EU approval and drinks coming to market although that is kinda super recent.... What do you think of declining sales what’s that now two quarters in a row though? might bleed here for a bit unless something comes to light
to correct the over valuation of the canna farms acquisition during the now deflated pot bubble.
https://www.investopedia.com/investing/impairment-charges/
What’s that 33 million dollar impairment charge for CannaFarms from the year-end audit?! That doesn’t sound good :-S
So the announcement comes just minutes before midnight and the # are pretty underwhelming... can’t say I’m too surprised- good news is sprinkled in and has plenty of potential lol GLTA
BIG --->>> VIVO Announces EU-GMP Certification
NAPANEE, ON, March 11, 2021 /CNW/ – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company") today announced that its Vanluven facility in Napanee Ontario has received EU-GMP (European Union Good Manufacturing Practices) certification from Germany’s Brandenburg health authority, the Landesamt für Arbeitsschutz, Verbraucherschutz und Gesundheit ("LAVG"). The certification takes effect immediately and enables VIVO, through its ABcann Medicinals subsidiary, to export product for sale into European and other markets requiring products to be manufactured under the rigorous GMP standards.
At the same time VIVO’s German subsidiary Beacon Medical Germany GmbH received an import licence from the authority to import medical cannabis flowers from Napanee to Germany and the EU.
VIVO’s President of European Operations, Andreas Sander said, "We are very excited about VIVO’s receipt of GMP certification from the German health authority of the state of Brandenburg. This is a major step forward in VIVO’s commitment to expand our medical cannabis business. It will allow us to start to provide patients, physicians and pharmacists with high quality medical cannabis flowers in Germany, the rest of Europe and beyond. It is a significant achievement that will help differentiate VIVO from many of its peers."
VIVO wants to thank the dedication of its GMP team for bringing this multi-year project to this successful milestone. GMP certification requires significant resources to achieve and to maintain. EU-GMP certification will likely provide VIVO the opportunity to pursue distribution opportunities not only in Germany but across the EU and in other global markets in which EU-GMP certification is required for market access. The Company is now working to achieve the first European sales of its Beacon Medical™ products, expected by Q3.
About VIVO Cannabis™
VIVO Cannabis™ is recognized for trusted, premium cannabis products and services. It holds production and sales licences from Health Canada and operates world-class indoor and seasonal airhouse cultivation facilities. VIVO has a collection of premium brands, each targeting different customer segments, including Canna Farms™, Beacon Medical™, Fireside™, Fireside-X™, Lumina™ and Canadian Bud Collection™. Harvest Medicine, VIVO’s patient-centric, scalable network of medical cannabis clinics, has serviced over 150,000 patient visits. VIVO is pursuing several partnership and product development opportunities and is focusing its international efforts on Germany and Australia. For more information visit: vivocannabis.com
Disclaimer for Forward-Looking Information
Certain statements in this news release are, or can be interpreted as, forward-looking statements, which are statements that are not purely historical, including statements regarding the beliefs, plans, expectations or intentions of VIVO and its management regarding the future. Forward-looking statements in this news release include that VIVO is expecting to bring its products to market in Europe, that physicians, patients and pharmacists will find value in VIVO products, that GMP certification will provide VIVO the opportunity to pursue additional international distribution opportunities, that GMP certification will help VIVO differentiate itself from its peers, and that it is targeting the first European sales of its products by Q3 2021.
Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including: VIVO has not yet shipped product to Germany for sale in that market and may be unsuccessful doing so; German physcians have not yet prescribed VIVO products, German pharmacists have not yet dispensed VIVO products, German patients have not yet taken VIVO products. The likelihood of these stakeholders interacting with VIVO products is not yet known; GMP may not provide VIVO with any significant additional international distribution opportunities; and, VIVO may fail to achieve the first European sales of its products by Q3 2021.
No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are urged to consider these factors, and the more extensive risk factors included in the Company’s management’s discussion and analysis for the three and nine months ended September 30, 2020, which is available on SEDAR, carefully in evaluating the forward-looking statements contained in this news release, and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements. The forward-looking statements in this news release are made as of the date hereof and the Company disclaims any intent or obligation to update publicly any such forward-looking statements, whether as a result of new information, future events or results or otherwise, except as required
SOURCE VIVO Cannabis Inc.
We knew they needed money. Remember when they announced and then pulled back the dilutive offering after the PPS dropped from 20¢ to 10¢?
Ahhhh so they needed money
VIVO Cannabis™ Prices $7 Million Overnight Marketed Public Offering
News Release Issued: Feb 23, 2021 (8:58am EST)
TORONTO, Feb. 23, 2021 /CNW/ - VIVO Cannabis Inc. (TSX: VIVO) ("VIVO" or the "Company") announced today the pricing of its previously announced overnight marketed public offering (the "Offering") of units of the Company (each, a "Unit" and, collectively, the "Units") at a price of $0.21 per Unit. The underwriters of the Offering have agreed to purchase 33,333,334 Units from the Company for total gross proceeds of approximately $7 million.
VIVO Cannabis Inc. Logo (CNW Group/VIVO Cannabis Inc.)
Each Unit will consist of one common share of the Company (each, a "Common Share") and one half of one Common Share purchase warrant of the Company (each whole Common Share purchase warrant, a "Warrant"). Each Warrant will be exercisable to acquire one Common Share (a "Warrant Share") for a period of 36 months following the Closing Date (as defined below) at an exercise price of $0.26 per Warrant Share, subject to adjustment in certain events.
The Offering is being conducted by a syndicate of underwriters including ATB Capital Markets Inc. as lead underwriter and sole bookrunner, Clarus Securities Inc., Echelon Wealth Partners and Eight Capital. The Offering is expected to close on or about February 26, 2021, and will be subject to market and other customary conditions, including approval of the Toronto Stock Exchange.
In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 15% of the Units offered in the Offering on the same terms and conditions (the "Over-Allotment Option"). The Over-Allotment Option may be exercised in whole or in part to purchase Common Shares, Warrants or Units as determined by the underwriters.
VIVO intends to use the net proceeds of the Offering for general working capital and corporate purposes.
The Units will be offered for sale in each of the provinces of Canada, except Quebec, pursuant to a prospectus supplement (the "Prospectus Supplement") to the Company's short form base shelf prospectus dated October 2, 2020 (the "Shelf Prospectus") and in the United States on a private placement basis to "qualified institutional buyers" pursuant to Rule 144A or in such other manner as to not require registration under the United States Securities Act of 1933, as amended (the "U.S. Securities Act").
The Prospectus Supplement will be filed today with the securities commissions or similar securities regulatory authorities in each of the provinces of Canada, excluding Quebec, with the pricing and terms of the Offering. The Prospectus Supplement and the Shelf Prospectus contain important detailed information about the Company and the Offering. Prospective investors should read the Prospectus Supplement, the Shelf Prospectus and the other documents the Company has filed before making an investment decision. Copies of the Prospectus Supplement, following filing thereof, and the Shelf Prospectus will be available on SEDAR at www.sedar.com.
No securities regulatory authority has either approved or disapproved of the contents of this news release. The Units have not been and will not be registered under the U.S. Securities Act or any state securities laws. Accordingly, the Units may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements. This news release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any province, state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such province, state or jurisdiction.
About VIVO Cannabis™
VIVO Cannabis™ is recognized for trusted, premium cannabis products and services. It holds production and sales licences from Health Canada and operates world-class indoor and seasonal airhouse cultivation facilities with proprietary plant-growing technology in Hope, British Columbia and Napanee, Ontario. VIVO has a collection of premium brands, each targeting different customer segments, including Canna Farms™, Beacon Medical™, Fireside™, Fireside-X™, Lumina™ and Canadian Bud Collection™. The Company is expanding its production capabilities and distribution network. Harvest Medicine, VIVO's patient-centric, scalable network of medical cannabis clinics, has serviced over 100,000 patient visits. VIVO is pursuing several partnership and product development opportunities and is focusing its international efforts on Germany and Australia. For more information visit: www.vivocannabis.com
Disclaimer for Forward-Looking Information:
All dollar amounts in this news release are in Canadian dollars. Certain statements in this news release are forward-looking statements, which are statements that are not purely historical, including statements regarding the beliefs, plans, expectations or intentions of VIVO and its management regarding the future. Forward-looking statements in this news release include statements regarding potential future offerings by the Company, the potential terms of same, the filing of any prospectus supplement with respect thereto, proposed use of proceeds, assuming completion, the anticipated closing date and the satisfaction of all necessary closing conditions, including the approval of the TSX. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including: the Offering may not be completed, the size and terms of the Offering, the satisfaction of the conditions of closing of the Offering, including any required TSX approvals, that there may be no financing available to the Company on satisfactory terms or at all, if and when the Company wishes to draw capital down under the Shelf Prospectus; that the COVID-19 pandemic may last longer and have a more significant impact on the Company's operations, financing abilities, the Canadian cannabis industry, or the global economy generally, than currently expected; and other factors beyond the Company's control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are urged to consider these factors, and the more extensive risk factors included in the Company's management's discussion and analysis for the three months ended September 30, 2020, which is available on SEDAR, carefully in evaluating the forward-looking statements contained in this news release, and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements. The forward-looking statements in this news release are made as of the date hereof and the Company disclaims any intent or obligation to update publicly any such forward-looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities laws.
SOURCE VIVO Cannabis Inc.
For further information: VIVO Investor Relations, Michael Bumby, Chief Financial Officer, +1 416-848-9839, ir@vivocannabis.com
VIVO Cannabis™ Announces Overnight Marketed Public Offering
News Release Issued: Feb 22, 2021 (5:04pm EST)
TORONTO, Feb. 22, 2021 /CNW/ - VIVO Cannabis Inc. (TSX: VIVO) ("VIVO" or the "Company") is pleased to announce that it has commenced an overnight marketed public offering of units of the Company (each, a "Unit" and, collectively, the "Units") at an issue price per Unit of $0.21, for gross proceeds of approximately $7 million (the "Offering"). Each Unit will consist of one common share of the Company (each, a "Common Share") and one half of one Common Share purchase warrant of the Company (each whole Common Share purchase warrant, a "Warrant"). Each Warrant will be exercisable to acquire one Common Share (a "Warrant Share") at an exercise price of $0.26 per Warrant Share for a period of 36 months following the Closing Date (as defined below).
VIVO Cannabis Inc. Logo (CNW Group/VIVO Cannabis Inc.)
The Offering is expected to be priced in the context of the market, with the final terms of the Offering to be determined at the time of pricing pursuant to the terms of an underwriting agreement to be entered into between the Company and ATB Capital Markets Inc., as lead underwriter and sole bookrunner, and a syndicate of underwriters (collectively, the "Underwriters"). There can be no assurance as to whether or when the Offering may be completed, or as to the actual size or terms of the Offering. The Offering is expected to close on or about February 26, 2021, and will be subject to market and other customary conditions, including approval of the Toronto Stock Exchange ("TSX").
The Company intends to grant to the Underwriters a 30-day option to purchase up to an additional 15% of the Units offered in the proposed Offering on the same terms and conditions (the "Over-Allotment Option"). The Over-Allotment Option may be exercised in whole or in part to purchase Common Shares, Warrants or Units as determined by the Underwriters.
VIVO intends to use the net proceeds of the Offering for general working capital and corporate purposes.
The Units will be offered for sale in each of the provinces of Canada, except Quebec, pursuant to a prospectus supplement to the Company's short form base shelf prospectus dated October 2, 2020 (the "Shelf Prospectus") and in the United States on a private placement basis to "qualified institutional buyers" pursuant to Rule 144A or in such other manner as to not require registration under the United States Securities Act of 1933, as amended (the "U.S. Securities Act").
No securities regulatory authority has either approved or disapproved of the contents of this news release. The Units have not been and will not be registered under the U.S. Securities Act or any state securities laws. Accordingly, the Units may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements. This news release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any province, state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such province, state or jurisdiction.
About VIVO Cannabis™
VIVO Cannabis™ is recognized for trusted, premium cannabis products and services. It holds production and sales licences from Health Canada and operates world-class indoor and seasonal airhouse cultivation facilities with proprietary plant-growing technology in Hope, British Columbia and Napanee, Ontario. VIVO has a collection of premium brands, each targeting different customer segments, including Canna Farms™, Beacon Medical™, Fireside™, Fireside-X™, Lumina™ and Canadian Bud Collection™. The Company is expanding its production capabilities and distribution network. Harvest Medicine, VIVO's patient-centric, scalable network of medical cannabis clinics, has serviced over 100,000 patient visits. VIVO is pursuing several partnership and product development opportunities and is focusing its international efforts on Germany and Australia. For more information visit: www.vivocannabis.com
Disclaimer for Forward-Looking Information:
All dollar amounts in this news release are in Canadian dollars. Certain statements in this news release are forward-looking statements, which are statements that are not purely historical, including statements regarding the beliefs, plans, expectations or intentions of VIVO and its management regarding the future. Forward-looking statements in this news release include statements regarding potential future offerings by the Company, the potential terms of same, the filing of any prospectus supplement with respect thereto, proposed use of proceeds, assuming completion, the anticipated closing date and the satisfaction of all necessary closing conditions, including the approval of the TSX. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including: the Offering may not be completed, the size and terms of the Offering, the satisfaction of the conditions of closing of the Offering, including any required TSX approvals, that there may be no financing available to the Company on satisfactory terms or at all, if and when the Company wishes to draw capital down under the Shelf Prospectus; that the COVID-19 pandemic may last longer and have a more significant impact on the Company's operations, financing abilities, the Canadian cannabis industry, or the global economy generally, than currently expected; and other factors beyond the Company's control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are urged to consider these factors, and the more extensive risk factors included in the Company's management's discussion and analysis for the three months ended September 30, 2020, which is available on SEDAR, carefully in evaluating the forward-looking statements contained in this news release, and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements. The forward-looking statements in this news release are made as of the date hereof and the Company disclaims any intent or obligation to update publicly any such forward-looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities laws.
Related Links
https://www.vivocannabis.com/
SOURCE VIVO Cannabis Inc.
For further information: VIVO Investor Relations, Michael Bumby, Chief Financial Officer, +1 416-848-9839, ir@vivocannabis.com
Whole sector is on fire... as always, I assume this will be the last to move (but now w the GW pharma buy out i find it more likely vivo gets bo- which shld fuel at least some speculation to that effect. They have been keen on precision dosing and production of consistent medicine... which shld be most attractive to any big pharma that wants to capitalize on generic epidiolex as well as other cannabinoid therapies that will now have lobby power in Congress
Radio silence... thght for sure I’d see some news here
$VVCIF Bullish https://schrts.co/RwENmCsi
VIVO Cannabis Announces Entry into Quebec and Provides Adult-Use Business Update
7:00 AM ET 1/4/21 | Dow Jones
TORONTO, Jan. 4, 2021 /CNW/ - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of premium cannabis products and services and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms") and ABcann Medicinals Inc. ("ABcann"), today announced its products have entered into the Quebec market with Canna Farms(TM) BC Kief as the province's first in the kief category. The Company also provided an update on its adult-use cannabis products across Canada.
"We're excited to bring additional solventless concentrates to consumers across the country," said Carole Chan, Chief Commercial Officer of VIVO Cannabis Inc. "As a leading licensed producer of craft premium cannabis products including concentrates, we look forward to diversifying our product offering in this growing niche category to better serve cannabis connoisseurs across the country."
Canna Farms(TM) Concentrates Available in Quebec
Quebec is the third largest market in Canada and the ninth province where VIVO products are available. Canna Farms(TM) BC Kief is the first in the kief category in Quebec, and through a partnership with provincial logistic partners, VIVO is expediting orders to meet demand both in-store and online.
VIVO Continues Concentrates Category Leadership Position
VIVO continues to maintain its solid market share in the cannabis concentrates space. The most recent publicly available information provided in the Ontario Cannabis Stores Quarterly Report for the period ending September 30, 2020 indicates Canna Farms(TM) and Fireside-X(TM) represent two of the top five leading concentrates brands, with a combined market-leading share of 38% in the category at Ontario retail stores.
Fireside(TM) Blaze Distillate Vape Launches in Alberta
VIVO launched its next generation Fireside(TM) Blaze, ultra-high THC distillate vape cartridge to consumers in Alberta last month. Extracted using state-of-the-art cryo-ethanol extraction and thin film distillation, there are no cutters, fillers, flavours, or additives in this pure, smooth and potent vape option.
Additional Canna Farms(TM) Cultivars Available in British Columbia
VIVO continued to expand its premium dry flower cultivar offering with the addition of three new Canna Farms(TM) listings in British Columbia: CBD Critical Mass, CBD Cannabliss and Cold Creek Kush. VIVO is focused on developing new cultivars and continues to invest in pheno hunting to provide unique genetics to all cannabis markets across its entire portfolio of brands. As the first licensed producer in British Columbia, the Canna Farms(TM) brand was built on a small-batch artisan approach to cannabis cultivation and continues to employ that practice to this day.
About VIVO Cannabis(TM)
VIVO Cannabis(TM) is recognized for trusted, premium cannabis products and services. It holds production and sales licences from Health Canada and operates world-class indoor and seasonal airhouse cultivation facilities. VIVO has a collection of premium brands, each targeting different customer segments, including Canna Farms(TM), Beacon Medical(TM), Fireside(TM), Fireside-X(TM), Lumina(TM) and Canadian Bud Collection(TM). Harvest Medicine, VIVO's patient-centric, scalable network of medical cannabis clinics, has serviced over 150,000 patient visits. VIVO is pursuing several partnership and product development opportunities and is focusing its international efforts on Germany and Australia. For more information visit: vivocannabis.com
Disclaimer for Forward-Looking Information
Certain statements in this news release are, or can be interpreted as, forward-looking statements, which are statements that are not purely historical, including statements regarding the beliefs, plans, expectations or intentions of VIVO and its management regarding the future. Forward-looking statements in this news release include that VIVO is expediting orders from Société Québécoise du Cannabis (SQDC) stores to meet demand, that its cannabis concentrates continue to do well in the market, and that consumers will find Fireside's store-locator feature useful..
Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including: orders from Société Québécoise du Cannabis (SQDC) stores may be limited or not materialize at all; that VIVO will not continue to do well in the cannabis concentrates market as new competition enters; that consumers will not find Fireside's store-locator feature useful; ; that the COVID-19 pandemic may last longer and have a more significant impact on the Company's operations, the Canadian cannabis industry, or the global economy generally, than currently expected; and other factors beyond the Company's control.
No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are urged to consider these factors, and the more extensive risk factors included in the Company's management's discussion and analysis for the three and nine months ended September 30, 2020, which is available on SEDAR, carefully in evaluating the forward-looking statements contained in this news release, and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements. The forward-looking statements in this news release are made as of the date hereof and the Company disclaims any intent or obligation to update publicly any such forward-looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities laws.
SOURCE VIVO Cannabis Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/January2021/04/c0186.html
/CONTACT:
VIVO Investor Relations, Michael Bumby, Chief Financial Officer, +1 416-848-9839, ir@vivocannabis.com
/Web site: https://www.vivocannabis.com/
Copyright CNW Group 2021
Anyone else see vivo @.15 this morn on one trade for 11k shares?
It's still possible for a raise, but IF they managed to sell off the "non core assets" they might survive without one for a bit, especially with 5 million plus shares of SKYLIGHT HEATH GROUP which was just up listed to the tsx and is climbing daily currently at 1.35.
They want to do another equity raise. They pulled the announced one after the PPS was cut in half. It has not recovered because everyone knows they want/have to go through with it.
I always thght vivo moved so slow in their expansion back in 2018 and when I saw how ALL the others were completely screwed by over expansion I thght people wld applaud Fishman for not going overboard and holding back. It looked like they had plenty of runway to profitability. I think they may ultimately pull it off without an equity raise to build confidence in their stock. Doesn’t look like insiders are ready to start buying but they ain’t selling their options and leaving in droves either so there is hope
I am learning not to like cannabis companies that aren't shortening the path to profitability and leave open the need for repeated trips to the equity well.
I’m hoping one day, people will wake up to this stock. It’s been a rough couple years lmao! Happy new year, may 2021 be the year VIVO comes alive; as delusional as it sounds- I’ve been thinking of doubling down on another 70k shares to avg down some more only thing stopping me is I can’t trust that they won’t do another raise for .15/share
This should help --->>> VIVO Cannabis™ Announces Entry into Quebec and Provides Adult-Use Business Update
TORONTO, Jan. 4, 2021 /CNW/ - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of premium cannabis products and services and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms") and ABcann Medicinals Inc. ("ABcann"), today announced its products have entered into the Quebec market with Canna Farms™ BC Kief as the province's first in the kief category. The Company also provided an update on its adult-use cannabis products across Canada.
Vivo Cannabis Logo (CNW Group/VIVO Cannabis Inc.)
"We're excited to bring additional solventless concentrates to consumers across the country," said Carole Chan, Chief Commercial Officer of VIVO Cannabis Inc. "As a leading licensed producer of craft premium cannabis products including concentrates, we look forward to diversifying our product offering in this growing niche category to better serve cannabis connoisseurs across the country."
Canna Farms™ Concentrates Available in Quebec
Quebec is the third largest market in Canada and the ninth province where VIVO products are available. Canna Farms™ BC Kief is the first in the kief category in Quebec, and through a partnership with provincial logistic partners, VIVO is expediting orders to meet demand both in-store and online.
VIVO Continues Concentrates Category Leadership Position
VIVO continues to maintain its solid market share in the cannabis concentrates space. The most recent publicly available information provided in the Ontario Cannabis Stores Quarterly Report for the period ending September 30, 2020 indicates Canna Farms™ and Fireside-X™ represent two of the top five leading concentrates brands, with a combined market-leading share of 38% in the category at Ontario retail stores.
Fireside™ Blaze Distillate Vape Launches in Alberta
VIVO launched its next generation Fireside™ Blaze, ultra-high THC distillate vape cartridge to consumers in Alberta last month. Extracted using state-of-the-art cryo-ethanol extraction and thin film distillation, there are no cutters, fillers, flavours, or additives in this pure, smooth and potent vape option.
Additional Canna Farms™ Cultivars Available in British Columbia
VIVO continued to expand its premium dry flower cultivar offering with the addition of three new Canna Farms™ listings in British Columbia: CBD Critical Mass, CBD Cannabliss and Cold Creek Kush. VIVO is focused on developing new cultivars and continues to invest in pheno hunting to provide unique genetics to all cannabis markets across its entire portfolio of brands. As the first licensed producer in British Columbia, the Canna Farms™ brand was built on a small-batch artisan approach to cannabis cultivation and continues to employ that practice to this day.
About VIVO Cannabis™
VIVO Cannabis™ is recognized for trusted, premium cannabis products and services. It holds production and sales licences from Health Canada and operates world-class indoor and seasonal airhouse cultivation facilities. VIVO has a collection of premium brands, each targeting different customer segments, including Canna Farms™, Beacon Medical™, Fireside™, Fireside-X™, Lumina™ and Canadian Bud Collection™. Harvest Medicine, VIVO's patient-centric, scalable network of medical cannabis clinics, has serviced over 150,000 patient visits. VIVO is pursuing several partnership and product development opportunities and is focusing its international efforts on Germany and Australia. For more information visit: vivocannabis.com
Disclaimer for Forward-Looking Information
Certain statements in this news release are, or can be interpreted as, forward-looking statements, which are statements that are not purely historical, including statements regarding the beliefs, plans, expectations or intentions of VIVO and its management regarding the future. Forward-looking statements in this news release include that VIVO is expediting orders from Société Québécoise du Cannabis (SQDC) stores to meet demand, that its cannabis concentrates continue to do well in the market, and that consumers will find Fireside's store-locator feature useful..
Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including: orders from Société Québécoise du Cannabis (SQDC) stores may be limited or not materialize at all; that VIVO will not continue to do well in the cannabis concentrates market as new competition enters; that consumers will not find Fireside's store-locator feature useful; ; that the COVID-19 pandemic may last longer and have a more significant impact on the Company's operations, the Canadian cannabis industry, or the global economy generally, than currently expected; and other factors beyond the Company's control.
No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are urged to consider these factors, and the more extensive risk factors included in the Company's management's discussion and analysis for the three and nine months ended September 30, 2020, which is available on SEDAR, carefully in evaluating the forward-looking statements contained in this news release, and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements. The forward-looking statements in this news release are made as of the date hereof and the Company disclaims any intent or obligation to update publicly any such forward-looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities laws.
SOURCE VIVO Cannabis Inc.
For further information: VIVO Investor Relations, Michael Bumby, Chief Financial Officer, +1 416-848-9839, ir@vivocannabis.com
Share buyback? Not anytime soon- they gonna milk the equity market once more when the time is right; then after all the new dilution and a reverse split, they may start buying back stock once they become solvent- not to sound cynical but that’s what I’m bracing for... but let’s hope you are right- sure has been a long time coming and w all the BS they promised, something has got to give: Novel formulation, beverages and other emulsifications, GMP, newly discovered compounds, results from trials in Australia, ramp up of business in Europe w Linneo, (maybe perhaps a Diageo partnership???) SOMETHING! JMJ
This is the year canna farms I debt of purchase is paid off. They are getting a new CEO that is committed for profitability. And I personally am picking up a few thousand here and there. Call me a fool but when other people are scared and selling is the time to slowly buying. The next thing I see them doing is buying their own shares back along with paying down debt once the last payment is made to canna farms. Have a great day.
You know, sometimes it is darkest before dawn- in vivo, I hope the sun rises again sometime soon but I’ll hang out and wait forever I guess
Lord I hope so!
"...I am very much looking forward to serving as Chair and interim CEO in the new year as we accelerate the path to positive cash flow."
bloated dead wood gone.
leaner, meaner and ready for profits ?
Go Richard.
Followers
|
72
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1845
|
Created
|
05/18/17
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |